Science Explorer Back to mapMap
Discussion
Institution · Brisbane · Australia

Q-Pharm

qpharm.com.auROR OpenAlex
Research works
10
▼ 100% vs 2018-21
Citations
362
37.9 per fractional work
Top-10% rate
21.2%
all institutions 10.0%
Open access
70%
world 40%
International
82%
world 18%
Q-Pharm

Not ranked overall: Q-Pharm is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Q-Pharm work in?

In all years, 58% of research at Q-Pharm is in Health Sciences, 34% in Life Sciences. Its largest fields are Medicine (58%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (7%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 6 fractional works · 58.4% of its workMedicine: 6 fractional works · 57.8% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 18.8% of its workInfectious Diseases: 1 fractional works · 6.6% of its workEpidemiology: 1 fractional works · 6.1% of its workOncology: 0 fractional works · 4.9% of its workPhysiology: 0 fractional works · 3.9% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 2.6% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 2.5% of its workRheumatology: 0 fractional works · 2.4% of its workPulmonary and Respiratory Medicine: 0 fractional works · 2.2% of its workGenetics: 0 fractional works · 2.1% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.8% of its workPharmacology: 0 fractional works · 1.7% of its workEmergency Medicine: 0 fractional works · 0.6% of its workReproductive Medicine: 0 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.6% of its workGeneral Health Professions: 0 fractional works · 0.6% of its workLife Sciences: 3 fractional works · 33.5% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 20.5% of its workMolecular Biology: 1 fractional works · 15.4% of its workGenetics: 0 fractional works · 4.2% of its workBiochemistry: 0 fractional works · 0.5% of its workCell Biology: 0 fractional works · 0.4% of its workImmunology and Microbiology: 1 fractional works · 7.0% of its workImmunology: 0 fractional works · 3.7% of its workParasitology: 0 fractional works · 2.1% of its workVirology: 0 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 3.4% of its workCognitive Neuroscience: 0 fractional works · 1.8% of its workEndocrine and Autonomic Systems: 0 fractional works · 1.8% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 2.6% of its workPharmacology: 0 fractional works · 2.0% of its workPharmaceutical Science: 0 fractional works · 0.6% of its workPhysical Sciences: 1 fractional works · 6.3% of its workComputer Science: 0 fractional works · 3.8% of its workComputational Theory and Mathematics: 0 fractional works · 3.0% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.7% of its workChemistry: 0 fractional works · 1.4% of its workAnalytical Chemistry: 0 fractional works · 0.8% of its workOrganic Chemistry: 0 fractional works · 0.5% of its workMathematics: 0 fractional works · 0.7% of its workStatistics and Probability: 0 fractional works · 0.7% of its workEngineering: 0 fractional works · 0.4% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 1.8% of its workPsychology: 0 fractional works · 1.8% of its workExperimental and Cognitive Psychology: 0 fractional works · 1.8% of its workALL ITS WORKQ-Pharm10fractional works, all years
Life Sciences34%Physical Sciences6%Health Sciences58%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Medicine657.8%
    2. Health Professions00.6%
    1. Biochemistry, Genetics and Molecular Biology220.5%
    2. Immunology and Microbiology17.0%
    3. Neuroscience03.4%
    4. Pharmacology, Toxicology and Pharmaceutics02.6%
    1. Computer Science03.8%
    2. Chemistry01.4%
    3. Mathematics00.7%
    4. Engineering00.4%
    1. Psychology01.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    Who are the top researchers at Q-Pharm?

    Ranked on the quality score, Joanne K. Marjason lead among researchers whose main affiliation is Q-Pharm.

    1. 1 Joanne K. Marjason Australia · #3,000,130 worldwide 562 citations · 19 works
    All ranked researchers at Q-Pharm

    What are the most cited papers from Q-Pharm?

    The most cited paper from Q-Pharm is "A Pilot Randomised Trial of Induced Blood-Stage Plasmodium falciparum Infections in Healthy Volunteers for Testing Efficacy of New Antimalarial Drugs" (James S. McCarthy, Silvana Sekuloski, Paul Griffin et al., 2011), with 185 citations. Next come "Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study" (158) and "A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults" (154).

    Most cited papers
    #PaperReleasedCitations
    1 A Pilot Randomised Trial of Induced Blood-Stage Plasmodium falciparum Infections in Healthy Volunteers for Testing Efficacy of New Antimalarial Drugs James S. McCarthy, Silvana Sekuloski, Paul Griffin et al. · PLoS ONE Open access 22 Aug 2011 185
    2 Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study Elliott Geoffrey Playford et al. · The Lancet Infectious Diseases Open access 3 Feb 2020 158
    3 A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults Antonios O. Aliprantis, Christine A. Shaw, Paul Griffin et al. · Human Vaccines & Immunotherapeutics Open access 29 Oct 2020 154
    4 A controlled human malaria infection model enabling evaluation of transmission-blocking interventions Katharine A. Collins, Claire Y. T. Wang, Matthew Adams et al. · Journal of Clinical Investigation Open access Feb 2018 153
    5 A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study James S. McCarthy, Thomas Rückle, Elhadj Djeriou et al. · Malaria Journal Open access 13 Sep 2016 130
    All 49 most cited papers, with filters and sorting

    Which research topics does Q-Pharm publish most on?

    By volume: Malaria Research and Control, Mosquito-borne diseases and control, bioluminescence and chemiluminescence research and Neonatal Health and Biochemistry.

    Malaria Research and Con…1Malaria Research and Control: 1 fractional worksMosquito-borne diseases …1Mosquito-borne diseases and control: 1 fractional worksbioluminescence and chem…0bioluminescence and chemiluminescence research: 0 fractional worksNeonatal Health and Biochemistry: 0 fractional worksComputational Drug Discovery Methods: 0 fractional worksRNA Interference and Gen…0RNA Interference and Gene Delivery: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksAsthma and respiratory diseases: 0 fractional worksVirus-based gene therapy research: 0 fractional worksViral Infections and Outbreaks Research: 0 fractional works
    Public Health, Environmental and Occupational HealthMolecular BiologyPediatrics, Perinatology and Child HealthComputational Theory and Mathematics4 others

    Area is fractional works; colour is the subfield each topic belongs to.

    1. 1 Malaria Research and Control Public Health, Environmental and Occupational Health 1 works
    2. 2 Mosquito-borne diseases and control Public Health, Environmental and Occupational Health 1 works
    3. 3 bioluminescence and chemiluminescence research Molecular Biology 0 works
    4. 4 Neonatal Health and Biochemistry Pediatrics, Perinatology and Child Health 0 works
    5. 5 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
    6. 6 RNA Interference and Gene Delivery Molecular Biology 0 works
    7. 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
    8. 8 Asthma and respiratory diseases Physiology 0 works
    9. 9 Virus-based gene therapy research Genetics 0 works
    10. 10 Viral Infections and Outbreaks Research Infectious Diseases 0 works

    How open and international is its research?

    Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available69.7%not open30.3%

    World: 40% of research is openly available.

    with international co-authors82.0%domestic only18.0%

    World: 18% is written across borders.

    How has Q-Pharm's research output changed?

    Output in 2022-2025 was 100% lower than in 2018-2021.

    20152020
    grewheldshrank

    The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

    Its share of all research

    Growing output can still be a shrinking share: all of science grows. This is Q-Pharm as a percentage of every work published that year, 0.000020% in 2020.

    0.000020%0.000040%0.000060%Q-Pharm0.0000074% in 20212020

    Fractional works of Q-Pharm over all fractional works that year. How the balance of science has shifted.

    Other research institutions in Brisbane

    All research institutions in Brisbane

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

    Discussion

    Ask a question or share a note about Q-Pharm. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.